Need help finding what you are looking for?
Contact Us
PUBLISHER: Transparency Market Research | PRODUCT CODE: 1459777
PUBLISHER: Transparency Market Research | PRODUCT CODE: 1459777
Plantar Fasciitis Treatment Market (Type: Medication Therapy, Orthotics, Shockwave Therapy, Surgery, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
PUBLISHED:
PAGES: 187 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Plantar Fasciitis Treatment Market - Scope of Report
TMR's report on the global plantar fasciitis treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global plantar fasciitis treatment market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global plantar fasciitis treatment market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the plantar fasciitis treatment market.
| Market Snapshot | |
|---|---|
| Market Value in 2022 | US$ 778.3 Mn |
| Market Value in 2031 | US$ 1.1 Bn |
| CAGR | 4.3% |
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global plantar fasciitis treatment market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global plantar fasciitis treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global plantar fasciitis treatment market.
The report delves into the competitive landscape of the global plantar fasciitis treatment market. Key players operating in the global plantar fasciitis treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global plantar fasciitis treatment market profiled in this report.
Key Questions Answered in Global plantar fasciitis treatment Market Report:
- What is the sales/revenue generated by plantar fasciitis treatment across all regions during the forecast period?
- What are the opportunities in the global plantar fasciitis treatment market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2031?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Plantar Fasciitis Treatment Market - Research Objectives and Research Approach
The comprehensive report on the global plantar fasciitis treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global plantar fasciitis treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global plantar fasciitis treatment market.
Product Code: TMRGL47658
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Plantar Fasciitis Treatment Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Product Definition
- 4.1.2. Industry Evolution/Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Plantar Fasciitis Treatment Market Analysis and Forecast, 2017-2031
5. Key Insights
- 5.1. Pipeline Analysis
- 5.2. Key Product/Brand Analysis
- 5.3. Key Mergers & Acquisitions
- 5.4. COVID-19 Pandemic Impact on Industry
6. Global Plantar Fasciitis Treatment Market Analysis and Forecast, by Type
- 6.1. Introduction & Definition
- 6.2. Key Findings/Developments
- 6.3. Market Value Forecast, by Type, 2017-2031
- 6.3.1. Medication Therapy
- 6.3.1.1. Oral
- 6.3.1.2. Parenteral
- 6.3.2. Shockwave Therapy
- 6.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)
- 6.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)
- 6.3.3. Surgery
- 6.3.4. Orthotics
- 6.3.5. Others
- 6.3.1. Medication Therapy
- 6.4. Market Attractiveness Analysis, by Type
7. Global Plantar Fasciitis Treatment Market Analysis and Forecast, by End-user
- 7.1. Introduction & Definition
- 7.2. Key Findings/Developments
- 7.3. Market Value Forecast, by End-user, 2017-2031
- 7.3.1. Hospitals
- 7.3.2. Clinics
- 7.3.3. Others
- 7.4. Market Attractiveness Analysis, by End-user
8. Global Plantar Fasciitis Treatment Market Analysis and Forecast, by Region
- 8.1. Key Findings
- 8.2. Market Value Forecast, by Region, 2017-2031
- 8.2.1. North America
- 8.2.2. Europe
- 8.2.3. Asia Pacific
- 8.2.4. Latin America
- 8.2.5. Middle East & Africa
- 8.3. Market Attractiveness Analysis, by Region
9. North America Plantar Fasciitis Treatment Market Analysis and Forecast
- 9.1. Introduction
- 9.2. Key Findings
- 9.3. Market Value Forecast, by Type, 2017-2031
- 9.3.1. Medication Therapy
- 9.3.1.1. Oral
- 9.3.1.2. Parenteral
- 9.3.2. Shockwave Therapy
- 9.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)
- 9.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)
- 9.3.3. Surgery
- 9.3.4. Orthotics
- 9.3.5. Others
- 9.3.1. Medication Therapy
- 9.4. Market Value Forecast, by End-user, 2017-2031
- 9.4.1. Hospitals
- 9.4.2. Clinics
- 9.4.3. Others
- 9.5. Market Value Forecast, by Country, 2017-2031
- 9.5.1. U.S.
- 9.5.2. Canada
- 9.6. Market Attractiveness Analysis
- 9.6.1. By Type
- 9.6.2. By End-user
- 9.6.3. By Country
10. Europe Plantar Fasciitis Treatment Market Analysis and Forecast
- 10.1. Introduction
- 10.2. Key Findings
- 10.3. Market Value Forecast, by Type, 2017-2031
- 10.3.1. Medication Therapy
- 10.3.1.1. Oral
- 10.3.1.2. Parenteral
- 10.3.2. Shockwave Therapy
- 10.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)
- 10.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)
- 10.3.3. Surgery
- 10.3.4. Orthotics
- 10.3.5. Others
- 10.3.1. Medication Therapy
- 10.4. Market Value Forecast, by End-user, 2017-2031
- 10.4.1. Hospitals
- 10.4.2. Clinics
- 10.4.3. Others
- 10.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 10.5.1. Germany
- 10.5.2. U.K.
- 10.5.3. France
- 10.5.4. Italy
- 10.5.5. Spain
- 10.5.6. Rest of Europe
- 10.6. Market Attractiveness Analysis
- 10.6.1. By Type
- 10.6.2. By End-user
- 10.6.3. By Country/Sub-region
11. Asia Pacific Plantar Fasciitis Treatment Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Key Findings
- 11.3. Market Value Forecast, by Type, 2017-2031
- 11.3.1. Medication Therapy
- 11.3.1.1. Oral
- 11.3.1.2. Parenteral
- 11.3.2. Shockwave Therapy
- 11.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)
- 11.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)
- 11.3.3. Surgery
- 11.3.4. Orthotics
- 11.3.5. Others
- 11.3.1. Medication Therapy
- 11.4. Market Value Forecast, by End-user, 2017-2031
- 11.4.1. Hospitals
- 11.4.2. Clinics
- 11.4.3. Others
- 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 11.5.1. China
- 11.5.2. Japan
- 11.5.3. India
- 11.5.4. Australia & New Zealand
- 11.5.5. Rest of Asia Pacific
- 11.6. Market Attractiveness Analysis
- 11.6.1. By Type
- 11.6.2. By End-user
- 11.6.3. By Country/Sub-region
12. Latin America Plantar Fasciitis Treatment Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Key Findings
- 12.3. Market Value Forecast, by Type, 2017-2031
- 12.3.1. Medication Therapy
- 12.3.1.1. Oral
- 12.3.1.2. Parenteral
- 12.3.2. Shockwave Therapy
- 12.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)
- 12.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)
- 12.3.3. Surgery
- 12.3.4. Orthotics
- 12.3.5. Others
- 12.3.1. Medication Therapy
- 12.4. Market Value Forecast, by End-user, 2017-2031
- 12.4.1. Hospitals
- 12.4.2. Clinics
- 12.4.3. Others
- 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.5.1. Brazil
- 12.5.2. Mexico
- 12.5.3. Rest of Latin America
- 12.6. Market Attractiveness Analysis
- 12.6.1. By Type
- 12.6.2. By End-user
- 12.6.3. By Country/Sub-region
13. Middle East & Africa Plantar Fasciitis Treatment Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Key Findings
- 13.3. Market Value Forecast, by Type, 2017-2031
- 13.3.1. Medication Therapy
- 13.3.1.1. Oral
- 13.3.1.2. Parenteral
- 13.3.2. Shockwave Therapy
- 13.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)
- 13.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)
- 13.3.3. Surgery
- 13.3.4. Orthotics
- 13.3.5. Others
- 13.3.1. Medication Therapy
- 13.4. Market Value Forecast, by End-user, 2017-2031
- 13.4.1. Hospitals
- 13.4.2. Clinics
- 13.4.3. Others
- 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.5.1. GCC Countries
- 13.5.2. South Africa
- 13.5.3. Rest of Middle East & Africa
- 13.6. Market Attractiveness Analysis
- 13.6.1. By Type
- 13.6.2. By End-user
- 13.6.3. By Country/Sub-region
14. Competition Landscape
- 14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
- 14.2. Market Share Analysis, by Company (2022)
- 14.3. Company Profiles
- 14.3.1. Hanger, Inc.
- 14.3.1.1. Company Overview
- 14.3.1.2. Product Portfolio
- 14.3.1.3. SWOT Analysis
- 14.3.1.4. Financial Overview
- 14.3.1.5. Strategic Overview
- 14.3.2. Bayer Group (Dr. Scholl's)
- 14.3.2.1. Company Overview
- 14.3.2.2. Product Portfolio
- 14.3.2.3. SWOT Analysis
- 14.3.2.4. Financial Overview
- 14.3.2.5. Strategic Overview
- 14.3.3. A. Algeo Limited
- 14.3.3.1. Company Overview
- 14.3.3.2. Product Portfolio
- 14.3.3.3. SWOT Analysis
- 14.3.3.4. Financial Overview
- 14.3.3.5. Strategic Overview
- 14.3.4. Bauerfeind AG
- 14.3.4.1. Company Overview
- 14.3.4.2. Product Portfolio
- 14.3.4.3. SWOT Analysis
- 14.3.4.4. Financial Overview
- 14.3.4.5. Strategic Overview
- 14.3.5. Superfeet Worldwide, Inc.
- 14.3.5.1. Company Overview
- 14.3.5.2. Product Portfolio
- 14.3.5.3. SWOT Analysis
- 14.3.5.4. Financial Overview
- 14.3.5.5. Strategic Overview
- 14.3.6. Ottobock SE & Co. KGaA (Ottobock Holding)
- 14.3.6.1. Company Overview
- 14.3.6.2. Product Portfolio
- 14.3.6.3. SWOT Analysis
- 14.3.6.4. Financial Overview
- 14.3.6.5. Strategic Overview
- 14.3.7. Pfizer, Inc.
- 14.3.7.1. Company Overview
- 14.3.7.2. Product Portfolio
- 14.3.7.3. SWOT Analysis
- 14.3.7.4. Financial Overview
- 14.3.7.5. Strategic Overview
- 14.3.8. Sanofi
- 14.3.8.1. Company Overview
- 14.3.8.2. Product Portfolio
- 14.3.8.3. SWOT Analysis
- 14.3.8.4. Financial Overview
- 14.3.8.5. Strategic Overview
- 14.3.9. GlaxoSmithKline plc
- 14.3.9.1. Company Overview
- 14.3.9.2. Product Portfolio
- 14.3.9.3. SWOT Analysis
- 14.3.9.4. Financial Overview
- 14.3.9.5. Strategic Overview
- 14.3.1. Hanger, Inc.
Product Code: TMRGL47658
List of Tables
- Table 01: Global Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
- Table 02: Global Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
- Table 03: Global Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Region, 2017-2031
- Table 04: North America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
- Table 05: North America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
- Table 06: North America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Country, 2017-2031
- Table 07: Europe Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
- Table 08: Europe Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
- Table 09: Europe Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
- Table 10: Asia Pacific Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
- Table 11: Asia Pacific Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
- Table 12: Asia Pacific Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
- Table 13: Latin America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
- Table 14: Latin America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
- Table 15: Latin America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
- Table 16: Middle East & Africa Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
- Table 17: Middle East & Africa Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
- Table 18: Middle East & Africa Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
List of Figures
- Figure 01: Global Plantar Fasciitis Treatment Market Size (US$ Mn) and Distribution (%), by Region, 2022-2031
- Figure 02: Global Plantar Fasciitis Treatment Market Revenue (US$ Mn), by Type, 2022
- Figure 03: Global Plantar Fasciitis Treatment Market Value Share, by Type, 2022
- Figure 04: Global Plantar Fasciitis Treatment Market Revenue (US$ Mn), by End-user, 2022
- Figure 05: Global Plantar Fasciitis Treatment Market Value Share, by End-user, 2022
- Figure 06: Global Plantar Fasciitis Treatment Market Value Share, by Region, 2022
- Figure 07: Global Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, 2023-2031
- Figure 08: Global Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022-2031
- Figure 09: Global Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023-2031
- Figure 10: Global Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022-2031
- Figure 11: Global Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023-2031
- Figure 12: Global Plantar Fasciitis Treatment Market Value Share Analysis, by Region, 2022-2031
- Figure 13: Global Plantar Fasciitis Treatment Market Attractiveness Analysis, by Region, 2023-2031
- Figure 14: North America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
- Figure 15: North America Plantar Fasciitis Treatment Market Attractiveness Analysis, by Country, 2023-2031
- Figure 16: North America Plantar Fasciitis Treatment Market Value Share Analysis, by Country, 2022-2031
- Figure 17: North America Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022-2031
- Figure 18: North America Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022-2031
- Figure 19: North America Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023-2031
- Figure 20: North America Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023-2031
- Figure 21: Europe Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
- Figure 22: Europe Plantar Fasciitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
- Figure 23: Europe Plantar Fasciitis Treatment Market Value Share Analysis, by Country/Sub-region, 2022-2031
- Figure 24: Europe Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022-2031
- Figure 25: Europe Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022-2031
- Figure 26: Europe Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023-2031
- Figure 27: Europe Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023-2031
- Figure 28: Asia Pacific Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
- Figure 29: Asia Pacific Plantar Fasciitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
- Figure 30: Asia Pacific Plantar Fasciitis Treatment Market Value Share Analysis, by Country/Sub-region, 2022-2031
- Figure 31: Asia Pacific Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022-2031
- Figure 32: Asia Pacific Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022-2031
- Figure 33: Asia Pacific Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023-2031
- Figure 34: Asia Pacific Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023-2031
- Figure 35: Latin America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
- Figure 36: Latin America Plantar Fasciitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
- Figure 37: Latin America Plantar Fasciitis Treatment Market Value Share Analysis, by Country/Sub-region, 2022-2031
- Figure 38: Latin America Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022-2031
- Figure 39: Latin America Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022-2031
- Figure 40: Latin America Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023-2031
- Figure 41: Latin America Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023-2031
- Figure 42: Middle East & Africa Plantar Fasciitis Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
- Figure 43: Middle East & Africa Plantar Fasciitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
- Figure 44: Middle East & Africa Plantar Fasciitis Treatment Market Value Share Analysis, by Country/Sub-region, 2022-2031
- Figure 45: Middle East & Africa Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022-2031
- Figure 46: Middle East & Africa Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022-2031
- Figure 47: Middle East & Africa Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023-2031
- Figure 48: Middle East & Africa Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023-2031
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.